Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 25, 2024. The transaction was executed in the open market at a price of $9.5052 per share, resulting in a total sale value of approximately $108,806. Following the sale, Borgeson directly holds a total of 7,177,116 shares in the company. The sale reflects a direct ownership transaction and was completed as an open market or private sale.

Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 25, 2024. The transaction was executed in the open market at a price of $9.5052 per share, resulting in a total sale value of approximately $108,806. Following the sale, Borgeson directly holds a total of 7,177,116 shares in the company. The sale reflects a direct ownership transaction and was completed as an open market or private sale.